In March 2025, the company introduced new plans for the immediate-to-purchaser giving of its Wegovy weight loss drug. The company established a new pharmacy, termed NovoCare, which would cost buyers $499 per month for use of the drug, less than fifty percent the expense of the drug by other pharmaceutical distribution networks.[fifty three]At the g